Professor Alan Rigby A.Rigby@hull.ac.uk
Professor of Statistics
Does glycated hemoglobin variability in type 2 diabetes differ depending on the diabetes treatment used in the Qatari population: implication on diabetes complication risk
People Involved
Miss Heather Moy H.Moy@hull.ac.uk
Mr Wayne Sheedy W.Sheedy@hull.ac.uk
Research Group Manager
Project Description
The purpose of this research is to better understand diabetes control and diabetes complications. It has been shown that fluctuation (changes) in long-term diabetes control may be related to the development of diabetes complications. In order to understand this, the study will look at whether changing diabetes treatment depending on the level of the blood sugar level (< 115mg/dl or <140mg/dl) will have different effects on diabetes control, specifically the HbA1c variability in 2 groups of patients with type 2 diabetes in Qatar.
Patient involvement in this research will last for 2 years to complete (114 weeks) and will encompass 20 visits when a blood sample will be taken and demographic details taken. Fasting blood samples will be taken and baseline 12 month, 24 month tests for nerves, kidney function and other blood markers of heart disease risk will be undertaken.
At the end of this period then anonymised data will be sent for analysis of the HbA1c variability for diabetes control and if this reflects diabetes complications
| Status | Project Complete |
|---|---|
| Funder(s) | Qatar Foundation |
| Value | £8,533.00 |
| Project Dates | Aug 1, 2016 - Jul 31, 2020 |
| Partner Organisations | Weill Cornell Medicine-Qatar |
You might also like
Shanghai-UK Industrial Challenge programme Innovate UK Feb 1, 2018 - Oct 31, 2021
Green Infrastructure Assets (GIAs) can often be perceived as an unnecessary cost, and something that must be done because of law or planning policy, however there are many business opportunities that GIAs can deliver in terms of cost, time savings, e...
Read More about Shanghai-UK Industrial Challenge programme Innovate UK.
Sir Jules Thorn PhD Scholarship Programme 2016 Sep 1, 2016 - Aug 31, 2019
Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lungs that affects about 15,000 people in the UK. There is no curative treatment and 5-year survival in IPF is worse than many cancers. Despite this, the pathogenesis of IPF...
Read More about Sir Jules Thorn PhD Scholarship Programme 2016.